U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT07516392) titled 'Study of a Polygenic Risk Score to Predict the Risk of Pancreatic Ductal Adenocarcinoma' on March 18.
Brief Summary: This case-control study aims to evaluate the role of a polygenic risk score in predicting the risk of pancreatic ductal adenocarcinoma (PDAC). The study will compare genetic risk profiles between individuals with PDAC and controls without the disease in order to assess whether a polygenic risk score may help identify individuals at higher risk. The findings may contribute to improving risk stratification and supporting future strategies for early identification and prevention of pancreatic cancer.
Study Start Date: A...